Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An announcement from Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) is now available.
Recordati Industria Chimica e Farmaceutica S.p.A. announced an update on its share buyback program, which was initiated to support stock options and performance shares plans for management. The company executed a series of buyback transactions from February 3 to February 7, 2025, acquiring a total of 67,525 shares at an average price of 58.8012 euros per share, holding 2,579,259 own shares by the end of the period. This strategic move is part of Recordati’s ongoing efforts to enhance shareholder value and align management incentives with company performance.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, with roots in Northern Italy dating back to the 1920s. The company provides therapeutic options in specialist drugs, general medicine, and rare diseases, operating in about 150 countries with over 4,450 employees. Recordati’s mission is to enable people to live their lives to the fullest, addressing both common and rare health challenges.
YTD Price Performance: 15.71%
Average Trading Volume: 25,289
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €12.07B
Find detailed analytics on REC stock on TipRanks’ Stock Analysis page.
